PUBLIC COMPANY
saveLuye Pharma Group Ltd
updated 12d ago
community read0 votes
🐶 often sniffed alongside
top 3pipeline
3
marketed
1
phase 3
0
catalysts ytd
2
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
1Marketed2Unknown
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1Mass Balance Study of [14C] LPM3770164 in Healthy Participants
- phase2A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With Schizophrenia
- phase2LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation
- phase1To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Food Effects of LY03021 in Healthy Chinese Subjects
- phase1A Food Effect Study of LY03020 in Healthy Subjects
- phase1A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
- phase2Identify Effective Doses of LY01021 in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART)
- phase1A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that